NWNan-Wei Wan

Nan-Wei Wan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nan-Wei Wan has a total of 93 co-authors. Here are the top co-authors by number of shared publications:

  • Yong-Zheng Chen

    Zunyi Medical University

    14 shared publications
  • Yong-Zheng Chen

    Guizhou Provincial Key Laboratory of Innovation and Manufacturing for Pharmaceutical, Green Pharmaceuticals Engineering Research Center of Guizhou Province, Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, School of Pharmacy

    12 shared publications
  • Hui-Hui Wang

    School of Pharmacy, Zunyi Medical University, Zunyi, China

    10 shared publications
  • Wen-Yong Han

    Guizhou Provincial Key Laboratory of Innovation and Manufacturing for Pharmaceuticals, School of Pharmacy, Zunyi Medical University, No. 6 West Xuefu Rd., Zunyi 563006, P. R. China

    8 shared publications
  • Hui‐Hui Wang

    Guizhou Provincial Key Laboratory of Innovation and Manufacturing for Pharmaceuticals Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education Green Pharmaceuticals Engineering Research Center of Guizhou Province School of Pharmacy Zunyi Medical University Zunyi China

    6 shared publications
  • Ran Ma

    Key Laboratory of Biocatalysis & Chiral Drug Synthesis of Guizhou Province Generic Drug Research Center of Guizhou Province Green Pharmaceuticals Engineering Research Center of Guizhou Province School of Pharmacy Zunyi Medical University Zunyi China

    6 shared publications

Latest Publications

  • Enantioselective Biohalogenation of Spiro‐Epoxyoxindoles Enabled by Engineered Halohydrin Dehalogenases

    by Hai‐Xia Zhang, Kui‐De Lu, Xian Gao, Peng‐Fei Cheng, Qun‐Gang Huang, Hui‐Hui Wang, Yong‐Zheng Chen, Nan‐Wei Wan

    We herein describe a biocatalytic halogenation approach that harnesses the reverse dehalogenation reaction of halohydrin dehalogenases. Through the integration of enzyme screening and structure‐guided protein engineering, a double mutant of HheC (T134S/W139M) was created for the enantioselective halogenation of spiro‐epoxyoxindoles, delivering chiral β‐haloalcohols in high yields (up to 50%) and optical purity (up to 98% ee ). Meanwhile, a nonenantioselective double mutant of HheG (I104F/N196G) was identified for the efficient halogenation of racemic or enantiopure spiro‐epoxyoxindoles, affording the corresponding β‐haloalcohols in up to 98% yield. The biohalogenation systems were performed using copper halides as the halogenating reagent under whole‐cell catalysis and exhibit satisfactory substrate generality. When cell‐free extract was used as the biocatalyst, several other halide salts were also proved effective for the biohalogenation reaction. Remarkably, seawater served as a natural halogenating agent, enabling gram‐scale synthesis of chiral β‐haloalcohols. Representative downstream transformations of chiral β‐haloalcohols further showcased the synthetic utility of the enantioselective biohalogenation platform. Together, these findings not only expand the catalytic repertoire of halohydrin dehalogenases but also provide a viable biohalogenation strategy for the synthesis of chiral β‐haloalcohols from readily available epoxides.

  • Enantioselective Biohalogenation of Spiro‐Epoxyoxindoles Enabled by Engineered Halohydrin Dehalogenases

    by Hai‐Xia Zhang, Kui‐De Lu, Xian Gao, Peng‐Fei Cheng, Qun‐Gang Huang, Hui‐Hui Wang, Yong‐Zheng Chen, Nan‐Wei Wan

    We herein describe a biocatalytic halogenation approach that harnesses the reverse dehalogenation reaction of halohydrin dehalogenases. Through the integration of enzyme screening and structure‐guided protein engineering, a double mutant of HheC (T134S/W139M) was created for the enantioselective halogenation of spiro‐epoxyoxindoles, delivering chiral β‐haloalcohols in high yields (up to 50%) and optical purity (up to 98% ee ). Meanwhile, a nonenantioselective double mutant of HheG (I104F/N196G) was identified for the efficient halogenation of racemic or enantiopure spiro‐epoxyoxindoles, affording the corresponding β‐haloalcohols in up to 98% yield. The biohalogenation systems were performed using copper halides as the halogenating reagent under whole‐cell catalysis and exhibit satisfactory substrate generality. When cell‐free extract was used as the biocatalyst, several other halide salts were also proved effective for the biohalogenation reaction. Remarkably, seawater served as a natural halogenating agent, enabling gram‐scale synthesis of chiral β‐haloalcohols. Representative downstream transformations of chiral β‐haloalcohols further showcased the synthetic utility of the enantioselective biohalogenation platform. Together, these findings not only expand the catalytic repertoire of halohydrin dehalogenases but also provide a viable biohalogenation strategy for the synthesis of chiral β‐haloalcohols from readily available epoxides.

  • Open Access

    Engineered halohydrin dehalogenase mediates remote enantiocontrolled dehalogenative hydroxylation via an unconventional mechanism

    by Xiao Jin, Hai-Xia Zhang, Kui-De Lu, Zhang-Yang Wang, Hui-Hui Wang, Yong-Zheng Chen, Nan-Wei Wan

    Expanding enzyme catalytic diversity is essential to unlocking the full potential of biocatalysis for green chemistry. Halohydrin dehalogenases are promiscuous biocatalysts that typically mediate the intramolecular dehalogenative cyclization of haloalcohols to form cyclic ethers, as well as the ring-opening of these O-heterocycles with various anionic nucleophiles. Here we report that engineered variants of the halohydrin dehalogenase HheC instead catalyze an intermolecular dehalogenative hydroxylation of ε-haloalcohols with remote enantiocontrol. Mechanistic investigations establish that an Asp-Arg dyad serves as the key catalytic motif responsible for this unconventional dehalogenation pathway. Through directed evolution, we further improve both the remote stereoselectivity and catalytic efficiency of the enzyme and systematically profile its substrate scope. The biocatalytic process is also successfully scaled to preparative and gram scales for the synthesis of chiral ε-haloalcohols and ε-diols. Our work uncovers an unusual dehalogenation mechanism and a practical platform for enantiocontrolled synthesis of chiral ε-substituted alcohols.


  • Biocatalytic Stereo-Perfect Desymmetrization of Oxetanes

    by Xin-Yu Da, Ming-Cheng Zuo, Tong-Qiu Lu, Yi Feng, Yang Zhao, Hui-Hui Wang, Yong-Zheng Chen, Nan-Wei Wan


  • Biocatalytic Noncanonical Enantioconvergent Synthesis of Vicinal Diols

    by Run-Ping Miao, Qian-Qian Wang, Cheng-Li He, Zhi-Yi Lu, Die Hu, Hui-Hui Wang, Yong-Zheng Chen, Donghui Wei, Nan-Wei Wan


  • Open Access

    Biocatalytic kinetic resolution for efficient and enantioselective synthesis of δ-haloalcohols and tetrahydrofurans

    by Yuan-Fei Wang, Xia Hua, Zhang-Yang Wang, Xiao Jin, Hui-Hui Wang, Yong-Zheng Chen, Nan-Wei Wan

    Expanding biocatalytic reactions to access previously inaccessible chemical transformations is of significant demand. Halohydrin dehalogenases represent a class of remarkably versatile biocatalysts that have been successfully explored in the asymmetric synthesis and transformation of epoxides as well as oxetanes. In this study, we extended their catalytic capabilities to establish a biocatalytic approach for the kinetic resolution of δ-haloalcohols. This approach enables the highly efficient and enantiocomplementary synthesis of diverse chiral δ-haloalcohols and tetrahydrofurans with good isolated yields (up to 50%) and high optical purities (up to >99% ee) on a preparative scale. These molecules are of significant interest in both synthetic and pharmaceutical chemistry. Remarkably, this biocatalytic method tolerates high substrate concentration up to 185 g/L, underscoring its synthetic potential for industrial applications. Furthermore, we propose a potential reaction mechanism based on a comprehensive analysis of various mutants and docking studies.


  • Artificial biocatalytic cascades for the enantiocomplementary synthesis of 3-hydroxy-γ-butyrolactones

    by Hong-Kang Fu, Tong-Qiu Lu, Ming-Cheng Zuo, Xin-Yu Da, Hui-Hui Wang, Yong-Zheng Chen, Nan-Wei Wan

    Optically active 3-hydroxy-γ-butyrolactone (3HBL) serves as a key chiral synthon in organic synthesis and medicinal chemistry. Although several bio-based synthesis routes exist, the development of greener alternatives for producing enantiopure 3HBL remains highly desirable. Herein, we present a novel biocascade platform for the enantiocomplementary synthesis of chiral 3HBL using bio-based 1,3-dichloropropanol as a prochiral precursor. This biocascade strategy combines halohydrin dehalogenase-catalyzed dehalogenation–cyanation reactions with nitrilase-mediated hydrolysis–cyclization reactions, enabling the synthesis of both (S)- and (R)-3HBL with good yields and high optical purities. Furthermore, comparative analysis of single-cell (coexpressed enzymes) and two-cell (separately expressed enzymes) biocascade systems revealed that the single-cell approach offers superior catalytic efficiency, delivering higher product yield with reduced biocatalyst loading.


  • Catalytic Characterization of α‐Regioselective Halohydrin Dehalogenase from Novosphingobium resinovorum

    by Hui‐Hui Wang, Miao An, Xin‐Yu Wang, Yang Zhao, Rui‐Ling Yan, Nan‐Wei Wan

    Halohydrin dehalogenases are highly valuable biocatalysts for chiral compound synthesis due to their diverse catalytic capabilities and inherent stereoselectivity. Historically, research on halohydrin dehalogenases is confined to a limited number of enzymes. However, with the advent of advanced gene mining methods, a growing number of halohydrin dehalogenases have been discovered and characterized, revealing a diverse array of new structures and catalytic functions. While halohydrin dehalogenases predominantly exhibit β ‐regioselectivity in the ring‐opening of styrene oxides, a few α‐regioselective halohydrin dehalogenases have also been identified. In this study, a new α‐regioselective halohydrin dehalogenase, HHDHnsr, is purified and analyzed, and its application in the azide‐mediated α‐regioselective azidolysis of styrene oxide is explored. The findings highlight the potential of HHDHnsr as α‐regioselective biocatalyst for the asymmetric synthesis of β ‐azidoalcohols, offering valuable insights for the future identification of α‐regioselective HHDHs in enzyme mining.

  • Open Access

    Biocatalytic enantioselective formation and ring-opening of oxetanes

    by Xia Hua, Yuan-Fei Wang, Xiao Jin, Hong-Yin Yu, Hui-Hui Wang, Yong-Zheng Chen, Nan-Wei Wan

    Although biocatalysis offers complementary or alternative approaches to traditional synthetic methods, the limited range of available enzymatic reactions currently poses challenges in synthesizing a diverse array of desired compounds. Consequently, there is a significant demand for developing novel biocatalytic processes to enable reactions that were previously unattainable. Herein, we report the discovery and subsequent protein engineering of a unique halohydrin dehalogenase to develop a biocatalytic platform for enantioselective formation and ring-opening of oxetanes. This biocatalytic platform, exhibiting high efficiency, excellent enantioselectivity, and broad scopes, facilitates the preparative-scale synthesis of chiral oxetanes and a variety of chiral γ-substituted alcohols. Additionally, both the enantioselective oxetane formation and ring-opening processes are proven scalable for large-scale transformations at high substrate concentrations, and can be integrated efficiently in a one-pot, one-catalyst cascade system. This work expands the enzymatic toolbox for non-natural reactions and will promote further exploration of the catalytic repertoire of halohydrin dehalogenases in synthetic and pharmaceutical chemistry.